Hans Olof Gunnar Johansson

Director/Board Member chez IMMUNOVIA AB

Profil

Hans Olof Gunnar Johansson is currently the Chairman at Doloradix AB and Myrtila AB.
He is also an Independent Director at Q-linea AB since 2018 and an Independent Director at Immunovia AB since 2016.
Additionally, he serves as a Director at Uppsala Innovation Centre AB, Single Technologies AB, SWElife, and Deputy Director at Duvbo Projektkonsult AB.
In his former positions, Johansson has served as the Chief Executive Officer at Biotage AB, Chairman at AroCell AB, Director at Affibody AB, Deputy Director at Duvbo Affarskonsult AB, Vice President-Laboratory Business Unit at Pharmacia Biotech AB, Head-Phadias Development Business at Phadia AB, and Vice President-Companion Diagnostics at Thermofisher, Inc.

Postes actifs de Hans Olof Gunnar Johansson

Sociétés	Poste	Début
IMMUNOVIA AB	Director/Board Member	09/12/2016
Q-LINEA AB	Director/Board Member	01/01/2018
Uppsala Innovation Centre AB	Director/Board Member	-
Single Technologies AB	Director/Board Member	-
Doloradix AB	Chairman	-
Myrtila AB	Chairman	-
Duvbo Projektkonsult AB	Corporate Officer/Principal	-
SWElife	Director/Board Member	-

Anciens postes connus de Hans Olof Gunnar Johansson

Sociétés	Poste	Fin
Duvbo Affarskonsult AB	Corporate Officer/Principal	-
░░░░░░░ ░░	░░░░░ ░░░░░░░░░ ░░░░░░░	-
░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░░░░ ░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-